Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | Virometix Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. | Immunome Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system. | ||
Founding Date | Founding Date 1991 | Founding Date 2002 | Founding Date 2001 | Founding Date 2009 | Founding Date 2008 |
Type | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Sunnyvale, US HQ | Locations Hørsholm, DK HQ | Locations Gent, BE HQ | Locations Schlieren, CH HQ | Locations Exton, US HQ |
Employees | Employees 669 | Employees 13 | Employees 1424% decrease | Employees 18 | Employees 264% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) N/A | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A | Revenue (est.) $14m (FY, 2023) |
Net income | Net income $86.1m (FY, 2014) | Net income N/A | Net income (€1.1m) (FY, 2016) | Net income N/A | Net income ($106.8m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 8m | Total funding raised $ 498.8m | Total funding raised $ 18.5m | Total funding raised $ 23.8m |